During development each neuron in C. elegans extends a precise number of processes from its cell body. This polarity is established normally in
sax-1 and
sax-2 mutants, but later in development ectopic neurites often emerge from the soma of select neurons. In addition,
sax-1 and
sax-2 mutants have neurons with enlarged, irregularly shaped cell bodies (Zallen et al. 1999). Whereas similar phenotypes have been seen in a variety of mutants known to disrupt neuron function, neurons in
sax-1 and
sax-2 mutants function normally suggesting that
sax-1 and
sax-2 may act more directly with the actin cytoskeleton to maintain neuron polarity. To ask if the late-emerging neurites in
sax-1 and
sax-2 mutants result from a deregulated axon guidance pathway, I made double mutants of
sax-1 and
sax-2 with various axon guidance mutants including
unc-34, a homolog of Enabled (M. Dell and G. Garriga, pers. comm.).
unc-34 lf mutants have axon guidance and early axon termination defects suggesting that
unc-34 functions to direct axon guidance and promote axon outgrowth during development. Surprisingly,
unc-34;
sax-1 and
unc-34;
sax-2 double mutants are enhanced for the ectopic neurite outgrowth defect. Furthermore, these ectopic neurites emerge after initial polarity has been established. These results suggest that
sax-1 and
sax-2 act in parallel with
unc-34 to inhibit ectopic neurite outgrowth. Since the early axon termination defects of
unc-34 suggest that it functions to promote axon outgrowth one interesting possibility is that
unc-34 is bifunctional. These results also demonstrate that
unc-34 plays a role during the establishment and maintenance of neuron polarity.
sax-1 encodes a S/T kinase related to the Ndr protein kinase in humans (62% id.) and flies (60 % id.) (Zallen and Bargmann submitted). While the function of the Ndr kinases is unknown, other closely related kinases have been shown to play a role in cell shape and polarity in nonneuronal cells. Since double mutant analysis places
sax-1 and
sax-2 in the same genetic pathway, I am in the process of cloning
sax-2 in order to identify other components of this kinase pathway. Progress in cloning and additional phenotypic characterization will be presented.